Agios Pharm (AGIO) revenue breakdown
By product, Product revenue, net is the largest at 82% of fiscal 2022 revenue; Milestone revenue grew fastest, 7% a year over 4 years.
By region, Product revenue, net - U.S. is the largest at 91% of fiscal 2025 revenue; Product revenue, net - Rest of world grew fastest, 4617% a year over 1 years.
Revenue by product
Fiscal years, as Agios Pharm reports them in its 10-K filings; fiscal 2022 total $14M.
| Products | 2017 | 2018 | 2019 | 2020 | 2022 | Share |
|---|---|---|---|---|---|---|
| Product revenue, net | — | $14M | $60M | $121M | $12M | 82% |
| Milestone revenue | $2M | $7M | $11M | $10M | $2M | 18% |
| Collaboration revenue – related party | $41M | $61M | $39M | $68M | — | — |
| Collaboration revenue – other | — | $13M | $8M | $4M | — | — |
Revenue by region
Fiscal years, as Agios Pharm reports them in its 10-K filings; fiscal 2025 total $54M.
| Regions | 2024 | 2025 | Share |
|---|---|---|---|
| Product revenue, net - U.S. | $36M | $49M | 91% |
| Product revenue, net - Rest of world | $103,000 | $5M | 9% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AGIO.
Open AGIO in InvestinglyQuestions
Where does Agios Pharm make its money?
In fiscal 2022, by product: Product revenue, net $12M, Milestone revenue $2M.
From Agios Pharm's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.